Abstract

51 - Early Apoptotic Cells as Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation is Safe and Effective: 1 Year Follow-Up and Biomarker Profile

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation Is Safe and Effective: 1 Year Follow-up
Dror Mevorach ... Reuven Or
Blood | VOL. 124
Dror Mevorach, et. al.Dror Mevorach ... Reuven Or
06 Dec 2014
Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance.
Lei Zhang ... Matthew Deberge
American Journal of Transplantation | VOL. 19
Lei Zhang, et. al.Lei Zhang ... Matthew Deberge
24 Sep 2018
Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial
Dror Mevorach ... Reuven Or
Biology of Blood and Marrow Transplantation | VOL. 20
Dror Mevorach, et. al.Dror Mevorach ... Reuven Or
15 Oct 2013
Faculty of 1000 evaluation for Single-infusion of donor mononuclear early apoptotic cells (ApoCell) as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation. A phase I/IIa clinical trial.
Anskar Leung
-
Anskar LeungAnskar Leung
16 Dec 2013
View more papers

More From: Cytotherapy

Paper Title
Journal
Date
Author
A successful haploidentical transplantation without conditioning regimen for a relapsed/refractory multiple myeloma patient after CAR T cell therapy
Zigang Dai ... Xiaoxi Zhou
Cytotherapy | VOL. -
Zigang Dai, et. al.Zigang Dai ... Xiaoxi Zhou
01 Dec 2024
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee.
M González Vicent ... C Díaz De Heredia
Cytotherapy | VOL. -
M González Vicent, et. al.M González Vicent ... C Díaz De Heredia
01 Dec 2024
GMP-Grade Fibronectin for Hollow-Fiber Bioreactor Cell Manufacture: MSC Case Study
Nathan D Frank ... Mindy M Miller
Cytotherapy | VOL. -
Nathan D Frank, et. al.Nathan D Frank ... Mindy M Miller
01 Dec 2024
Considerations for manufacturing of cell and gene medicines for clinical development
Mark W Lowdell
Cytotherapy | VOL. -
Mark W LowdellMark W Lowdell
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.